Published in

Impact Journals, Oncotarget, 11(9), p. 9714-9727, 2018

DOI: 10.18632/oncotarget.23882

Links

Tools

Export citation

Search in Google Scholar

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO